Core Viewpoint - Huakang Clean experienced a stock price decline of 2.16% on November 4, with a current price of 29.96 CNY per share and a market capitalization of 3.229 billion CNY [1] Financial Performance - For the period from January to September 2025, Huakang Clean achieved a revenue of 1.431 billion CNY, representing a year-on-year growth of 32.59% [2] - The net profit attributable to the parent company was 61.1567 million CNY, showing a significant year-on-year increase of 211.46% [2] Shareholder Information - As of October 20, 2025, the number of Huakang Clean's shareholders decreased by 1.61% to 10,400, while the average circulating shares per person increased by 1.64% to 7,011 shares [2] - The company has cumulatively distributed dividends of 40.0214 million CNY since its A-share listing, with 29.4614 million CNY distributed over the past three years [3] Stock Market Activity - Huakang Clean's stock has seen a year-to-date increase of 48.60%, but has declined by 3.48% over the last five trading days and 10.73% over the last 20 days [1] - The company has appeared on the "Dragon and Tiger List" twice this year, with the most recent appearance on July 31 [1] Business Overview - Huakang Clean, established on November 12, 2008, and listed on January 28, 2022, specializes in the research, design, implementation, and operation of medical purification systems, along with the sale of related medical equipment and consumables [1] - The revenue composition of Huakang Clean includes 85.24% from purification system integration, 8.53% from medical consumables sales, 3.74% from medical equipment sales, 1.88% from operation and maintenance services, and 0.61% from other sources [1] - The company operates within the pharmaceutical and biological industry, specifically in the medical device sector, and is involved in concepts such as medical waste treatment, assisted reproduction, medical devices, smart healthcare, and artificial intelligence [1]
华康洁净跌2.16%，成交额3167.78万元，主力资金净流出80.58万元